( NASDAQ-NMS:BIOD )

News from Biodel Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

26 Oct, 2016, 19:18 ET Biodel Announces Intent to Further Adjourn Annual Meeting until Thursday, November 3

Biodel Inc. (Nasdaq: BIOD) ("Biodel") announced today that, assuming it has not received from stockholders sufficient proxies to approve the...


24 Oct, 2016, 16:01 ET Biodel Announces Adjournment of Annual Meeting until Thursday, October 27, Urges Stockholders to Vote

Biodel Inc. (Nasdaq: BIOD) ("Biodel") announced that its 2016 Annual Meeting of Stockholders ("Annual Meeting"), scheduled for October 24, 2016,...


17 Oct, 2016, 08:30 ET Proxy Advisory Firms, ISS, Glass Lewis Recommend Biodel Stockholders Vote in Favor of the Proposals Necessary to Complete the Company's Planned Combination with Albireo Limited

Biodel Inc. (Nasdaq: BIOD) ("Biodel" or the "Company") is pleased to announce that two leading proxy voting advisory firms, Institutional...


05 Oct, 2012, 16:00 ET Biodel to Host Analyst / Investor Research and Development Meeting on October 11th in New York

Biodel Inc. (Nasdaq: BIOD) today announced it will be hosting a meeting for analysts and investors on October 11, 2012 in New York. During the...


27 Sep, 2012, 06:00 ET Biodel to Present at European Association for the Study of Diabetes on October 2, 2012 in Berlin, Germany

 Biodel Inc. (Nasdaq: BIOD) will present experimental data from its ultra-rapid-acting prandial insulin analog program at the 48th annual...


13 Sep, 2012, 06:30 ET Biodel Announces Phase 2 Clinical Trial Initiation Of Ultra-Rapid-Acting Insulin Candidate BIOD-123

Biodel Inc. (Nasdaq: BIOD) today announced the initiation of a Phase 2 clinical trial of its proprietary recombinant insulin (RHI)-based...


10 Aug, 2012, 06:00 ET Biodel to Present at 2012 Wedbush PacGrow Lifesciences Management Access Conference

Biodel Inc. (Nasdaq: BIOD) announced today that management will be presenting an overview of the company's technologies, development programs, and...


26 Jul, 2012, 06:00 ET Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas

 Biodel Inc. (Nasdaq: BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health...


10 Jul, 2012, 06:00 ET Biodel to Present at JMP Securities Healthcare Conference

 Biodel Inc. (Nasdaq: BIOD) announced today that management will be presenting an overview of the Company's technologies, development...


27 Jun, 2012, 06:00 ET Biodel Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

Biodel Inc. (Nasdaq: BIOD) announced today that it has received notice from the NASDAQ Stock Market that the Company has regained compliance with...


22 Jun, 2012, 09:15 ET Biodel Announces $18.5 Million Private Placement

 Biodel Inc. (NASDAQ: BIOD) today announced that it has entered into a definitive securities purchase agreement with a group of...


08 Jun, 2012, 16:01 ET Biodel Obtains Exclusive License to Aegis Therapeutics' Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations

Biodel Inc. (Nasdaq: BIOD) and Aegis Therapeutics, LLC (Aegis) today announced a partnership providing Biodel an exclusive worldwide license to...


10 May, 2012, 15:32 ET Biodel Announces Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market

Biodel Inc. (Nasdaq: BIOD) today announced that NASDAQ has approved the Company's request to voluntarily transfer the listing of its shares of...


10 May, 2012, 06:00 ET Biodel Reports Second Quarter Fiscal Year 2012 Financial Results

 Biodel Inc. (Nasdaq: BIOD) today reported financial results for the second fiscal quarter ended March 31, 2012. Highlights since Beginning...


07 May, 2012, 06:00 ET Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012

 Biodel Inc. (Nasdaq: BIOD) will issue its second quarter fiscal year 2012 financial results on May 10, 2012.  Following the release of...


02 May, 2012, 06:30 ET Biodel's Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office

Biodel Inc. (Nasdaq: BIOD) announced today that it has received a notice of allowance from the European Patent Office for patent claims covering...


26 Apr, 2012, 16:30 ET Ms. Julia R. Brown and Mr. Davey S. Scoon Join Biodel Board of Directors

 Biodel Inc. (Nasdaq: BIOD) today announced the appointments of Ms. Julia R. Brown and Mr. Davey S. Scoon to its Board of Directors.  The...


15 Apr, 2012, 20:00 ET Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations

 Biodel Inc. (Nasdaq: BIOD) today announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and...


14 Mar, 2012, 16:00 ET Biodel to Provide Update on Stabilized Glucagon Program at ROTH Conference Today

Biodel Inc. (Nasdaq: BIOD) today will provide an update on its stabilized glucagon program at the ROTH 24th Annual OC Growth Stock...


08 Mar, 2012, 06:00 ET Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012

 Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Errol De Souza, President and CEO of Biodel, will present a corporate update at the ROTH...


08 Feb, 2012, 16:00 ET Biodel Reports First Quarter Fiscal Year 2012 Financial Results

Biodel Inc. (Nasdaq: BIOD) today reported financial results for the first quarter ended December 31, 2011. Dr. Errol De Souza, president and...


03 Feb, 2012, 06:59 ET Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012

 Biodel Inc. (Nasdaq: BIOD) will issue its first quarter fiscal year 2012 financial results on February 8, 2012.  Following the release...


06 Jan, 2012, 06:59 ET Biodel Inc. to Present at 30th Annual JPMorgan Healthcare Conference on January 12th, 2012

Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Errol De Souza, President and CEO of Biodel, will present a corporate update at the 30th...


06 Dec, 2011, 16:06 ET Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results

Biodel Inc. (Nasdaq: BIOD) today reported financial results for the fourth quarter ended September 30, 2011. Fourth Quarter Operating...


01 Dec, 2011, 16:00 ET Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011

Biodel Inc. (Nasdaq: BIOD) will issue its fourth quarter fiscal year 2011 financial results on December 6, 2011.  Following the release of the...